At L.E.K. the opening estimate is not a warmup. It becomes the denominator for the decision.
L.E.K. Consulting was founded in 1983 by three ex-Bain London partners. Official capabilities cover growth, M&A, private equity support, pricing, and performance improvement. Industries on lek.com/industries include life sciences, MedTech, PE, consumer, and industrials. Headcount disagrees across CoachNed pages: practice-cases says 27 offices and roughly 2,300 employees; a ranking table ~2,400; the boutique comparison ~4,100. Show the range or skip the number. The Apply page says the process "differs slightly by region" and mixes experiential and case interviews (quantitative and strategic). It does not support a universal SHL screen or a universal written case. Candidate reports describe two 30-minute cases in round one and a written case of about 60 minutes in some finals. Titles: Associate is undergraduate entry; Consultant is post-MBA (filed US base $185,000 in 2025). McKinsey Associate is the MBA hire. Ignore the word; check the base on the L.E.K. salary page. CoachNed is independent and not affiliated with L.E.K.
What L.E.K. actually runs
L.E.K. publishes three cases with no answers: an aircraft brainteaser, a brewery profit-volatility case, and a pharmaceutical market sizing and pricing case. Two of the three require an estimate. Official live-interview tips tell you to restate facts, take time, stick to the approach, ask clarifying questions, hypothesise aloud, come up with an answer while staying willing to rethink, and be yourself. Decode those prompts on L.E.K. practice cases.
| Stage | What is confirmed vs reported | How to treat it |
|---|---|---|
| Several rounds | Confirmed on the Apply page | Invitation is sequence of truth |
| Experiential interviews | Confirmed | Motivation and evidence; see L.E.K. behavioral questions |
| Case interviews | Quantitative or strategic | Candidate-led; you request data |
| Written case | Reported ~60 minutes with slides in some finals | Confirm; not a global rule |
| Online test | Not a universal L.E.K. rule | Only if named |
PhD / Life Sciences Specialist tracks use the same firm but heavier indication and patient-flow math. Filed 2025 base for those titles was $152,500.
How L.E.K. differs from McKinsey interviewer-led and BCG candidate-led
Control is BCG-like: you drive. McKinsey would sequence the exhibits for you. The L.E.K. twist is estimation frequency. McKinsey embeds sizing occasionally. BCG often opens with it. L.E.K. uses the number as the frame for pricing, investment, or go/no-go. Candidates who rush the estimate to "get to the real case" spend the rest of the hour defending a denominator they never pressure-tested.
Sector vocabulary is the other split. Life sciences and PE diligence show up more than in a generalist McKinsey round. A BCG profitability tree without a patient-flow or TAM chain is the wrong first move on the official pharma prompt. The written case, where it appears, is a 60-minute compression test, not a McKinsey PEI.
Worked snippet: indication sizing and price (L.E.K. flavour)
Prompt. A MedTech client wants to price a diagnostic for a condition with 2.1 million diagnosed patients in the US. Current standard of care is $180 per test, twice a year, 60% tested. The new test is 30% more accurate at catching progressors. Hospital labs will switch only if the budget impact is under 8%. What price, and is the market worth a sales-force build?
Clarify. Accuracy matters only if it changes treatment. Ask for the share of patients whose management would change, and whether the 8% is per-department or system-wide.
Structure. (1) Addressable tests today, (2) incremental tests if accuracy lifts testing, (3) price that clears the 8% budget rule, (4) sales-force cost versus contribution.
Math. Tests today: 2.1 million × 60% × 2 = 2.52 million. Spend today: 2.52 million × $180 = $454 million. Eight percent of that budget = $36 million of room. If volume is unchanged, price can rise $36 million / 2.52 million ≈ $14, to about $194. If accuracy lifts testing from 60% to 70%, tests = 2.1 million × 70% × 2 = 2.94 million. At $180 that is $529 million, a 16% budget jump, which breaks the 8% rule unless price falls. Solving 2.94 million × P ≤ $454 million × 1.08 = $490 million gives P ≤ $167. The "premium for accuracy" and the budget constraint fight each other.
Recommendation. Do not launch at a premium if the 8% cap is real and testing expands. Price at $165–$170 with a outcomes contract, or keep $194 only in accounts that will not expand volume. Sales-force build is a no until the price-volume pair is chosen. Risk: the 8% is a talking point, not a policy. Next step: 15 lab directors on whether volume would expand.
That is L.E.K.-shaped: the estimate is the case, and the constraint kills the obvious premium.
How to prepare this week
- Work L.E.K.'s three official cases cold before third-party material.
- Grade one sizing on CoachNed.
- If a written case is named, rehearse a 60-minute packet.
- Map titles before you compare offers: L.E.K. salary (Associate ≠ McKinsey Associate; Consultant filed at $185K).
Sources
- L.E.K. Apply and interview preparation
- Capabilities and industries
- CoachNed practice cases (official three; candidate-reported 30-minute pairs and 60-minute written)
- H-1B Consultant base $185,000 (2023–2025 filings) on the salary page; headcount disagreement noted above
Frequently asked questions
Candidate-led or interviewer-led?
Candidate-led in the material L.E.K. publishes. Confirm live.
Is every candidate given a written case?
No. Region and level vary. Official pages do not fix it globally.
What is an L.E.K. Associate?
Usually the undergraduate hire, not the MBA hire. CoachNed is independent practice, not affiliated with L.E.K. Cases on CoachNed are AI-simulated. Region changes the process.